However, the relevance of the limited family structure differs for TP53 mutation carriers as compared to BRCA mutation carriers, because TP53 mutations have a markedly higher penetrance in males and carriers have a markedly lower age at first cancer diagnosis, typically debuting before 45 years of age. This evidence concerns the gene TP53 and cancer.